ITRMF (Iterum Therapeutics) Float Percentage Of Total Shares Outstanding: 99.24% (As of Jun. 26, 2026)


What is Iterum Therapeutics Float Percentage Of Total Shares Outstanding?

Iterum Therapeutics ITRMF +18.86% Float Percentage Of Total Shares Outstanding is 99.24% as of Jun. 26, 2026. The stock has 4 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Iterum Therapeutics's float shares is 52.88 Mil. Iterum Therapeutics's total shares outstanding is 53.29 Mil. Iterum Therapeutics's float percentage of total shares outstanding is 99.24%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Iterum Therapeutics's Insider Ownership is 1.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Iterum Therapeutics's Institutional Ownership is 2.65%.

Iterum Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Iterum Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=52.88/53.29
=99.24%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 99.24% mean?
Iterum Therapeutics (ITRMF) has a Float Percentage Of Total Shares Outstanding of 99.24% as of Jun. 26, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Iterum Therapeutics and its competitors.
Is Iterum Therapeutics' Float Percentage Of Total Shares Outstanding too high?
Iterum Therapeutics' current Float Percentage Of Total Shares Outstanding is 99.24%.
How does Iterum Therapeutics' Float Percentage Of Total Shares Outstanding compare to ENSC and PPCB?
Iterum Therapeutics' Float Percentage Of Total Shares Outstanding of 99.24% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on Iterum Therapeutics and its competitors. Iterum Therapeutics's current Float Percentage Of Total Shares Outstanding is 99.24%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iterum Therapeutics stock overvalued right now?
Iterum Therapeutics (ITRMF) has a current Float Percentage Of Total Shares Outstanding of 99.24%. The current Float Percentage Of Total Shares Outstanding is 99.24%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For Iterum Therapeutics (ITRMF), the current Float Percentage Of Total Shares Outstanding is 99.24% as of Jun. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Iterum Therapeutics Business Description

Address 3 Dublin Landings, North Wall Quay, Dublin 1, Dublin, IRL, D01 C4E0
Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.